Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-03-12 @ 12:12 AM
Study NCT ID:
NCT03819660
Status:
TERMINATED
Last Update Posted:
2023-11-30
First Post:
2019-01-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3
Sponsor:
Catalyst Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-13
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-23
First Submit QC Date:
None
Study First Post Date:
2019-01-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-01
Results First Submit QC Date:
None
Results First Post Date:
2023-11-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-29
Last Update Post Date:
2023-11-30
Last Update Post Date Type:
ACTUAL